Uncovering drug repurposing candidates for head and neck cancers: insights from systematic pharmacogenomics data analysis
Effective treatment options for head and neck squamous cell carcinoma (HNSCC) are currently lacking. We exploited the drug response and genomic data of the 28 HNSCC cell lines, screened with 4,518 compounds, from the PRISM repurposing dataset to uncover repurposing drug candidates for HNSCC. A total...
Saved in:
Main Authors: | Chai, Annie Wai Yeeng, Tan, Aik Choon, Cheong, Sok Ching |
---|---|
Format: | Article |
Published: |
Nature Research
2021
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/26083/ https://doi.org/10.1038/s41598-021-03418-1 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell Systems
by: Lee, Beverly K.B., et al.
Published: (2018) -
Blood vessels of the head and neck
by: Aung, Htar Htar
Published: (2011) -
Drug repurposing of clinically-approved drugs to target epithelial-mesenchymal transition using in silico analysis
by: Ong, Chun Hao
Published: (2021) -
COVID-19: How effective are the repurposed drugs and novel agents in treating the infection?
by: Suet-May, Chow, et al.
Published: (2022) -
Imaging in head and neck: CT and MRI
by: Hassan, Radhiana
Published: (2016)